Status:
COMPLETED
Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion
Lead Sponsor:
University of California, Los Angeles
Conditions:
Abortion, Induced
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Current practice for the provision of late second trimester abortion (dilation and evacuation, or D\&E) often involves the administration of digoxin into the fetal compartment to induce fetal demise p...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age greater than or equal to 18 years
- Singleton viable gestation
- Identifying as primarily English-speaking
- Body mass index less than 40 kilograms/meters squared
- Already a consented patient for second-trimester abortion procedure with digoxin to be performed for termination of pregnancy at the study site
- No medical contraindication to digoxin (i.e., no cardiac dysfunction, no renal dysfunction, no hypersensitivity to digoxin)
Exclusion
Key Trial Info
Start Date :
October 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02277249
Start Date
October 1 2012
End Date
October 1 2014
Last Update
January 13 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.